liver disease

State Prisons Fail To Offer Cure To 144,000 Inmates With Deadly Hepatitis C

Jul 9, 2018
Creative Commons/Pixabay

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

Many of the 49 states that responded to questions about inmates with hepatitis C cited high drug prices as the reason for denying treatment. The drugs can cost up to $90,000 for a course of treatment.

Searching For A New Liver; Traveling For A Transplant

Mar 22, 2016
Seth Doraiswami
Karen Shakerdge / WHYY

Last summer, Seth Doraiswami, a stonemason from Belmont, Massachusetts planned a trip to Wisconsin, to get a new liver.

Doraiswami, 33, was born with a liver disease called biliary atresia, which causes bile ducts to become inflamed and the liver to scar. At 11 weeks old he had a risky procedure done that saved his life, and for years he took antibiotics to stay healthy. But in December of 2014, while he was living in Italy with his wife and son, the disease caught up with him again.

Medicaid Denies Nearly Half Of Requests For Hepatitis C Drugs: Study

Nov 23, 2015
A cluster of hepatitis viruses, as seen through a transmission electron microscope.
CDC

People with hepatitis C who sought prescriptions for highly effective but pricey new drugs were significantly more likely to get turned down if they had Medicaid coverage than if they were insured by Medicare or private commercial policies, a recent study found.